sur Electromedical Technologies, Inc. (NASDAQ:EMED)
Electromedical Provides Update to Shareholders
Electromedical Technologies, Inc. (OTC PINK:EMED), a leader in bioelectronic medical devices, announced recent achievements and strategic advancements to its shareholders. The company reported a 17% increase in revenue for the year ended 2023 compared to 2022, partly due to strong demand for its innovative products.
EMED established a strategic partnership with Lionheart Health, known for its accolades in medical aesthetics. The collaboration aims to expand the reach of EMED's Wellness Pro Infinity™ device, featuring advanced iDNA technology and Digital Synthesis. The device is set for shipment in September-October, with significant pre-orders already in place.
Financially, the company has renegotiated creditor agreements to strengthen its financial position and onboarded a medical group with 200 sales representatives to bolster market expansion. These efforts position EMED for significant sales growth and enhanced financial performance.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Electromedical Technologies, Inc.